Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas

American Journal of Clinical Pathology

Volumn 142, Issue 2, 2014, Pages 150-156

  Ohgami, Robert S ^a   Zhao, Shuchun ^a   Natkunam, Yasodha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Large B cell lymphoma; PD 1+ T cells; T cell histiocyte rich large B cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; OBINUTUZUMAB; PREDNISONE; PROGRAMMED DEATH 1 RECEPTOR; RITUXIMAB; T LYMPHOCYTE ANTIGEN; VINCRISTINE; PDCD1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; T CELL HISTIOCYTE RICH LARGE B CELL LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE; B CELL LYMPHOMA; CYTOLOGY; LARGE B-CELL LYMPHOMA; LYMPHOCYTE COUNT; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PD-1+ T CELLS; RETROSPECTIVE STUDY; T-CELL HISTIOCYTE RICH LARGE B-CELL LYMPHOMA; YOUNG ADULT;

LARGE B-CELL LYMPHOMA; PD-1+ T CELLS; T-CELL HISTIOCYTE RICH LARGE B-CELL LYMPHOMA;

ADOLESCENT; ADULT; B-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84907207691     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPFJWKQ6GTVQE6     Document Type: Article

References (23)

1. Jin HT, Ahmed R, Okazaki T. Role of PD-1 in regulating T-cell immunity. Curr Top Microbiol Immunol. 2011;350:17-37.
2. Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887-3895.
3. Shinohara T, Taniwaki M, Ishida Y, et al. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 1994;23:704-706.
4. Dorfman DM, Brown JA, Shahsafaei A, et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30:802-810.
5. Yu H, Shahsafaei A, Dorfman DM. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 2009;131:33-41.
6. Iwai Y, Okazaki T, Nishimura H, et al. Microanatomical localization of PD-1 in human tonsils. Immunol Lett. 2002;83:215-220.
7. Good-Jacobson KL, Szumilas CG, Chen L, et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010;11(6):535-542.
8. Krishnan C, Warnke RA, Arber DA, et al. PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis. Am J Surg Pathol. 2010;34:178-189.
9. Sage PT, Francisco LM, Carman CV, et al. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol. 2013;14:152-161.
10. Churchill HR, Roncador G, Warnke RA, et al. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol. 2010;41:1726-1734.
11. Batra R, Medeiros BC, Zehnder JL, et al. Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma? Appl Immunohistochem Mol Morphol. 2012;20:325-330.
12. Ohgami RS, Zhao S, Ohgami JK, et al. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2012;36:1619-1628.
13. Ohgami RS, Ohgami JK, Pereira IT, et al. Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies. Leukemia. 2011;25:1439-1443.
14. Sohani AR, Jaffe ES, Harris NL, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma. Am J Surg Pathol. 2011;35:1666-1678.
15. Bruggemann M, White H, Gaulard P, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies: report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia. 2007;21:215-221.
16. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
17. Felgar RE, Steward KR, Cousar JB, et al. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas. Am J Pathol. 1998;153:1707-1715.
18. Hartmann S, Doring C, Jakobus C, et al. Nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma: endpoints of a spectrum of one disease? PLoS One. 2013;8:e78812.
19. Muenst S, Hoeller S, Willi N, et al. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers. 2010;29:47-53.
20. Carreras J, Lopez-Guillermo A, Roncador G, et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol. 2009;27:1470-1476.
21. Chen BJ, Chapuy B, Ouyang J, et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res. 2013;19:3462-3473.
22. Andorsky DJ, Yamada RE, Said J, et al. Programmed death ligand 1 is expressed by non-Hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin Cancer Res. 2011;17:4232-4244.
23. Andersen MH. PD-L1 expression in B-cell lymphomas and virus-associated malignancies [letter]. Clin Cancer Res. 2013;19:4017.